|
⚲
|
| Keyboard |
| Horowitz Bruce
✚
|
|
|---|---|
| CIK # | 0001703622 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001703622] | |
| 4 | [0001703622] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Provectus Biopharmaceuticals Inc | |
| Horowitz Bruce |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Provectus Biopharmaceuticals Inc PVCT
Series D-1 Convertible Preferred Stock · derivative
|
2021-06-20 | Option exercise | $0.00 | ||
|
Provectus Biopharmaceuticals Inc PVCT
8% Secured Convertible Promissory Notes due 2021 · derivative
|
2021-06-20 | Option exercise | $0.00 | ||
|
Provectus Biopharmaceuticals Inc PVCT
8% Secured Convertible Promissory Notes due 2021 · derivative
|
2021-06-17 | Grant | 38,473 | $0.00 | |
|
Provectus Biopharmaceuticals Inc PVCT
Common Stock
|
2020-11-10 | Grant | 800,000 | $0.00 | |
|
Provectus Biopharmaceuticals Inc PVCT
Stock Options (Right to Buy) · derivative
|
2020-11-10 | Grant | 2,425,000 | $0.00 |